Kiora Pharmaceuticals Operating Cycle Over Time
| KPRX Stock | USD 2.26 0.08 3.42% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Kiora Pharmaceuticals Performance and Kiora Pharmaceuticals Correlation. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. Expected growth trajectory for Kiora significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Kiora Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Kiora Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Kiora's accounting equity. The concept of intrinsic value - what Kiora Pharmaceuticals' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Kiora Pharmaceuticals' price substantially above or below its fundamental value.
Understanding that Kiora Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Kiora Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Kiora Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Cycle Analysis
Compare Kiora Pharmaceuticals and related stocks such as Aprea Therapeutics, Biocardia, and Acurx Pharmaceuticals LLC Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APRE | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| BCDA | 46.3787 | 2 K | 65.0878 | 65.0878 | 91.385 | 261 | 113 | 173 | 260 | 79.6486 | 52.8621 | 52.8621 | 54.2641 | 48.2075 | 48.2075 | 55.44 | 52.67 |
| ACXP | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| INAB | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 57.0312 | 51.33 | 45.62 |
| APVO | 517 | 517 | 517 | 517 | 517 | 523 | 103 | 128 | 141 | 1 K | 201 | 109 | 293 | 293 | 293 | 337 | 369 |
| HCWB | 223 | 223 | 223 | 223 | 223 | 223 | 223 | 223 | 223 | 223 | 223 | 146 | 146 | 197 | 82.7895 | 95.21 | 178 |
| PHIO | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ADIL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| RNAZ | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Kiora Pharmaceuticals and related stocks such as Aprea Therapeutics, Biocardia, and Acurx Pharmaceuticals LLC Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Kiora Pharmaceuticals | KPRX |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 332 Encinitas Boulevard, |
| Exchange | NASDAQ Exchange |
USD 2.26
Additional Tools for Kiora Stock Analysis
When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.